Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 18/11/13 → 31/12/14 |
Clinical Trial Phase
- Phase III (a & b)
A randomised, open label Phase 3 study of Carfilzomib, Melaphalan, and prednisone versus Bortezomib, Melaphalan, and prednisone in transplant-ineligible patients with newly diagnosed multiple myeleom
- Schwarer, Anthony (Primary Chief Investigator (PCI))
Project: Research